Altered activity of lysophospholipase D, which produces bioactive lysophosphatidic acid and choline, in serum from women with pathological pregnancy

Molecular Human Reproduction

Volumn 15, Issue 5, 2009, Pages 301-310

  Tokumura, A ^a   Kume, T ^a   Taira, S ^a   Yasuda, K ^b   Kanzaki, H ^b  

^a Institute of Health Biosciences   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Abnormal pregnancy; Autotaxin; Lysophosphatidic acid; Lysophosphatidylcholine; Lysophospholipase D

Indexed keywords

AUTOTAXIN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPASE; LYSOPHOSPHOLIPASE D; UNCLASSIFIED DRUG; ALKYLGLYCEROPHOSPHOETHANOLAMINE PHOSPHODIESTERASE; CHOLINE; ENPP2 PROTEIN, HUMAN; GLYCEROPHOSPHOCHOLINE CHOLINEPHOSPHODIESTERASE; INORGANIC PYROPHOSPHATASE; LYSOPHOSPHOLIPID; MULTIENZYME COMPLEX; PHOSPHATASE; PHOSPHOCHOLINE PHOSPHATASE; PHOSPHODIESTERASE; PHOSPHODIESTERASE I;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VIVO STUDY; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE STUDY; VASCULAR DISEASE; WESTERN BLOTTING; ANIMAL; BLOOD; CHEMISTRY; ENZYMOLOGY; GESTATIONAL AGE; METABOLISM; PREGNANCY;

ANIMALS; CHOLINE; FEMALE; GESTATIONAL AGE; HUMANS; LYSOPHOSPHATIDYLCHOLINES; LYSOPHOSPHOLIPIDS; MULTIENZYME COMPLEXES; OBSTETRIC LABOR, PREMATURE; PHOSPHODIESTERASE I; PHOSPHORIC DIESTER HYDROLASES; PHOSPHORIC MONOESTER HYDROLASES; PRE-ECLAMPSIA; PREGNANCY; PYROPHOSPHATASES;

EID: 64549152824     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gap017     Document Type: Article

References (50)

1. Bandoh K, Aoki J, Hosono H, Kobayashi S, Kobayashi T, Murakami-Murofushi K, Tsujimoto M, Arai H, Inoue K. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem 1999; 274:27776-27785.
2. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
3. Bollen M, Gijsbers R, Ceulemans H, Stalmans W, Stefan C. Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit Rev Biochem Mol Biol 2000;35:393-432.
4. Branch DW, Mitchell MD, Miller E, Palinski W, Witztum JL. Pre-eclampsia and serum antibodies to oxidized low-density lipoprotein. Lancet 1994; 343:645-646.
5. Coffey CG. Cellular bases for the lipid-related aspects of preeclampsia. Med Hypothesis 2003;60:716-719.
6. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: Current concepts. Am J Obstet Gynecol 1998;179:1359-1375.
7. Endresen MJ, Lorentzen B, Henriksen T. Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultures endothelial cells. Am J Obstet Gynecol 1992;167:440-447.
8. Endresen MJ, Lorentzen B, Henriksen T. Increased lipolytic activity of sera from pre-eclamptic women due to the presence of a lysophospholipase. Scan J Clin Lab Invest 1993;53:733-739.
9. Giganti A, Rodriguz M, Fould B, Moulhart N, Cogé F, Chomarat P, Galizzi J, Valet P, Saulnier-Blache J, Boutin JA et al. Murine and humanautotaxina α, β, and γ isoforms. Gene organization, tissue distribution, and biochemical characterization. J Biol Chem 2008;283:7776-7789.
10. Goetzl EG, Dolezalova H, Kong Y, Hu YL, Jaffe RB, Kalli KR, Conover CA. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res 1999; 59 5370-5375.
11. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371:75-84.
12. Hama K, Aoki J, Inoue A, Endo T, Amano T, Motoki R, Kanai M, Ye X, Chun J, Matsuki N et al. Embryo spacing and implantation timing are differentially regulated by LPA3-mediated lysophosphatidic acid signaling in mice. Biol Reprod 2007;77:954-959.
13. Hecht JH, Weiner JA, Post SR, Chun J. Ventricular zone gene-1 (Vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J Cell Biol 1996; 135:1071-1083.
14. Hinokio K, Yamano S, Nakagawa K, Irahara M, Kamada M, Tokumura A, Aono T. Lysophosphatidic acid stimulates nuclear and cytoplasmic maturation of golden hamster immature oocytes in vitro via cumulus cells. Life Sci 2002;70:759-767.
15. Huang K, Li S, Fung WC, Hulmes JD, Reik L, Pan YCE, Low MG. Purification and characterization of glycosyl-phosphatidylinositol-specific phospholipase D. J Biol Chem 1990;265:17738-17745.
16. Kobayashi T, Yamano S, Murayama S, Ishikawa H, Tokumura A, Aono T. Effect of lysophosphatidic acid on the preimplantaion development of mouse embryo. FEBS Lett 1994;351:38-40.
17. Komatsu J, Yamano S, Kuwahara A, Tokumura A, Irahara M. The signaling pathways linking to lysophosphatidic acid-promoted meiotic maturation in mice. Life Sci 2006;79:506-511.
18. Kotarsky K, Boketoft Å, Bristulf J, Nilsson NE, Norberg Å, Hansson S, Owman C, Sillard R, Leeb-Lundberg LMF, Olde B. Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes. J Pharmacol Exp Ther 2006;318:619-628.
19. 2 concentrations in serum and amniotic fluid in association with preterm labor. Am J Obstet Gynecol 2000;183:1537-1543.
20. Kunikata K, Yamano S, Tokumura A, Aono T. Effect of lysophosphatidic acid on the ovum transport in mouse oviducts. Life Sci 1999; 65 833-840.
21. 5. J Biol Chem 2006;281:23589-23597.
22. 2 levels are elevated in severe preeclampsia. Am J Obstet Gynecol 1995;172:998-1002.
23. Liszewska E, Renaud P, Billon-Denis E, Dubois O, Robin P, Charpigny G. Lysophosphatidic acid signaling during embryo development in sheep: involvement in prostaglandin synthesis. Endocrinology 2009;150 422-434.
24. Liu Z, Armant DR. Lysophosphatidic acid regulates murine blastocyst development by transactivation of receptors for heparin-binding EGF-like growth factor. Exp Cell Res 2004;296:317-326.
25. Llurba E, Casals E, Domínguez C, Delgado J, Mercadé I, Crispi F, Martin-Gallán P, Cabero L, Gratacós E. Atherogenic lipoprotein subfraction profile in preeclamptic women with and without high triglycerides: Different pathophysiologic subsets in preelcampsia. Metab Clin Exp 2005;54:1504-1509.
26. 9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 2003;278 25600-25606.
27. 2 in serum during normal and pathological pregnancy. Gynecol Obstet Invest 1993;36:96-101.
28. Schumacher KA, Classen HG, Späth M. Platelet aggregation evoked in vitro and in vivo by phosphatidic acids and lysoderivatives: identity with substances in aged serum (DAS). Thromb Haemost 1979;42:631-640.
29. Seo H, Kim M, Choi Y, Lee CK, Ka H. Analysis of lysophospatidic acid (LPA) receptor and LPA-induced endometrial prostaglandin-endoperoxide synthase 2 expression in the porcine uterus. Endocrinology 2008; 149:6166-6175.
30. Shiokawa S, Sakai K, Akimoto Y, Suzuki N, Hanashi H, Nagamatsu S, Iwashita M, Nakamura Y, Hirano H, Yoshimura Y. Function of the small guanosine triphosphate-binding protein RhoA in the process of implantation. J Clin Endocrinol Metab 2000;85:4742-4749.
31. Stracke ML, Krutzsch HC, Unsworth EJ, Årestad A, Cioce V, Schiffmann E, Liotta LA. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 1992; 267:2524-2529.
32. Tabata K, Baba K, Shiraishi A, Ito M, Fujita N. The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem Biophys Res Commun 2007;363:861-866.
33. Takacs P, Kauma SW, Sholley MM, Walsh SW, Dinsmoor MJ, Green K. Increased circulating lipid peroxides in severe preeclampsia activate NF-κB and upregulate ICAM-1 in vascular endothelial cells. FASEB J 2001;15:279-281.
34. Tanaka M, Okudaira S, Kishi Y, Ohkawa R, Iseki S, Ota M, Noji S, Yatomi Y, Aoki J, Arai H. Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem 2006;281:25822-25830.
35. Tokumura A. Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluid. Biochim Biophys Acta 2002;1582:18-25.
36. Tokumura A, Fukuzawa K, Akamatsu Y, Yamada S, Suzuki T, Tsukatani H. Identification of vasodepressor phospholipid in crude soybean lecithin. Lipids 1978;13:468-472.
37. Tokumura A, Fukuzawa K, Isobe J, Tsukatani H. Lysophosphatidic acid-induced aggregation of human and feline platelets: structure-activity relationship. Biochem Biophys Res Commun 1981;99:391-398.
38. Tokumura A, Harada K, Fukuzawa K, Tsukatani H. Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma. Biochim Biophys Acta 1986;875:31-38.
39. Tokumura A, Miyake M, Nishioka Y, Yamano S, Aono T, Fukuzawa K. Production of lysophosphatidic acids by lysophospholipase D in human follicular fluids of in vitro fertilization patients. Biol Reprod 1999; 61:195-199.
40. Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, Fukuzawa K. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 2002a;277:39436-39442.
41. Tokumura A, Kanaya Y, Miyake M, Yamano S, Irahara M, Fukuzawa K. Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy. Biol Reprod 2002b; 67 1386-1392.
42. Tokumura A, Kume T, Fukuzawa K, Tahara M, Tasaka K, Aoki J, Arai H, Yasuda K, Kanzaki H. Peritoneal fluids from patients with certain gynecologic tumor contain elevated levels of bioactive lysophospholipase D activity. Life Sci 2007;80:1641-1649.
43. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GM, Inoue K, Aoki J et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 2002;158:227-233.
44. Van Meeteren LA, Frederiks F, Giepmans BNG, Pedrosa MFF, Billington SJ, Jost BH, Tambourgi DV, Moolenaar WH. Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine. J Biol Chem 2004;270: 10833-10836.
45. Van Meeteren LA, Ruurs P, Stortelers C, Bouwman P, van Rooijen MA, Pradere JP, Pettit TR, Wakelam MJO, Saulnier-Blashe JS, Mummery CL et al. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol Cell Biol 2006; 26 5015-5022.
46. Vigne J, Murai JT, Arbogast BW, Jia W, Fisher SJ, Taylor RN. Elevated nonesteriofied fatty acid concentrations in severe preeclamsia shift the isoelectric characteristics of plasma albumin. J Clin Endocrinol 1997; 82:3786-3792.
47. 3-mediated lysophosphatidic acid signaling in embryo implantation and spacing. Nature 2005; 435:104-108.
48. Yoshida K, Nishida W, Hayashi K, Ohkawa Y, Ogawa A, Aoki J, Arai H, Sobue K. Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo. Circulation 2003;108 1746-1752.
49. Zaitsu K, Ohkura Y. New fluorogenic substrates for horseradish peroxidase: Rapid and sensitive assays for hydrogen peroxide and the peroxidase. Anal Biochem 1980;109:109-113.
50. Zhang C, Baker DL, Yasuda S, Makarova N, Balazs L, Johnson LR, Marathe GK, McIntyre TM, Xu Y, Prestwich GD et al. Lysophosphatidic acid induces neointima formation through PPARγ activation. J Exp Med 2004; 199:763-774.